Teriflunomide (Leflunomide) Promotes Cytostatic, Antioxidant, and Apoptotic Effects in Transformed Prostate Epithelial Cells: Evidence Supporting a Role for Teriflunomide in Prostate Cancer Chemoprevention
Teriflunomide (TFN) is an inhibitor of de novo pyrimidine synthesis and the active metabolite of leflunomide. Leflunomide is prescribed to patients worldwide as an immunomodulatory and anti-inflammatory disease-modifying prodrug. Leflunomide inhibited the growth of human prostate cancer xenographs i...
Main Authors: | Numsen Hail, Jr, Ping Chen, Lane R. Bushman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800041 |
Similar Items
-
Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide
by: Irina Terekhova, et al.
Published: (2020-11-01) -
Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels
by: Nicte S. Fajardo-Robledo, et al.
Published: (2022-02-01) -
Teriflunomide in patients with multiple sclerosis
by: N. Y. Lasch, et al.
Published: (2015-12-01) -
Lichenoid drug eruption induced by teriflunomide
by: Fatima-Zahra Agharbi, et al.
Published: (2023-01-01) -
An update of teriflunomide for treatment of multiple sclerosis
by: Oh J, et al.
Published: (2013-04-01)